Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
09/11/2009 | WO2009110939A2 Drug delivery system for pharmaceuticals and radiation |
09/11/2009 | WO2009109332A1 Bombesin analog peptide antagonist conjugates |
09/11/2009 | WO2009109327A2 Method and product for obtaining thin radioactive layers to be used in radiation dosimetry and in medicine |
09/11/2009 | CA2717427A1 Bombesin analog peptide antagonist conjugates |
09/10/2009 | US20090227686 Methods of preventing, treating and diagnosing disorders of protein aggregation |
09/10/2009 | US20090226369 STQ Peptides |
09/10/2009 | US20090226368 Androgen-Receptor (AR) Ligands for Use in the Treatment and Diagnosis of AR-Related Pathologies |
09/10/2009 | US20090226367 Compositions comprising an anti-ca125 antibody and a cytotoxic compound and their use for the treatment of cancer |
09/10/2009 | US20090226366 Choline: Early Detector of Cancer |
09/09/2009 | EP2098523A1 Novel compounds with affinity for amyloid |
09/09/2009 | EP2098514A1 Preparation of compounds useful for the detection of hypoxia |
09/09/2009 | EP2098251A1 Method and product for obtaining thin radioactive layers to be used in radiation dosimetry and in medicine |
09/09/2009 | EP2097112A2 Methods of imaging employing chelating agents |
09/09/2009 | EP2097111A2 Heterodimers of glutamic acid |
09/09/2009 | EP1648925B1 Bicyclic peptide imaging agents |
09/09/2009 | EP1517918B9 Peptides having affinity for a phospholipid and uses |
09/09/2009 | CN101528270A 68ga-labeled peptide-based radiopharmaceuticals |
09/09/2009 | CN101528269A Preparation and utility of opioid analgesics |
09/09/2009 | CN101524549A New anti-cancer compound |
09/09/2009 | CN100536926C Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals |
09/08/2009 | US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
09/08/2009 | US7585839 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
09/08/2009 | US7585509 Erb-2 receptor targeting peptide |
09/08/2009 | US7585492 Contrast agents used in various embodiments may be any organic or semi-organic compounds which have the desired effect of affinity to certain target tissues/cells to either bind with them or react with them or react with metabolic products of the target; dosage monitoring and therapy success mechanism |
09/08/2009 | CA2284750C Steroid sulfamates, method for the production and use thereof |
09/07/2009 | CA2624883A1 Directed therapy |
09/03/2009 | WO2009107139A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
09/03/2009 | WO2009106566A2 Therapy selection method |
09/03/2009 | WO2009089383A3 Inhibitors of carbonic anhydrase ix |
09/03/2009 | WO2009027452A3 Radiopharmaceutical composition |
09/03/2009 | WO2008148877A3 Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
09/03/2009 | WO2008145283A3 Use of radiolabelled phenyloxyaniline derivatives for imaging diseases associated with peripheral benzodiazepin receptor's activation |
09/03/2009 | WO2008112224A3 High radioactivity thallium solutions and uses thereof |
09/03/2009 | US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
09/03/2009 | US20090220420 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr) |
09/03/2009 | US20090220419 99mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS |
09/03/2009 | US20090220418 Multimodal imaging using a three compartment polymer nanoparticle with cell specificity |
09/03/2009 | US20090220417 Methods of using il-31 monoclonal antibodies to reduce inflammation |
09/03/2009 | US20090220416 Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders |
09/03/2009 | US20090220415 Diagnostic system for the detection of skin cancer |
09/03/2009 | CA2717060A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
09/02/2009 | EP2094311A2 Improved linkers for anchoring targeting ligands |
09/02/2009 | EP0995448B1 Compound for diagnosing malignant tumors |
09/02/2009 | CN101518651A Pastille slow-release material and preparation method and application thereof |
09/02/2009 | CN100535013C Selective targeting of tumor vasculature using antibody molecules |
09/02/2009 | CN100534535C Improved linkers for pharmaceutical compounds |
09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
09/01/2009 | US7582295 Glycoprotein receptor complex; cancer therapy |
09/01/2009 | US7582281 Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging |
09/01/2009 | US7582280 Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications |
09/01/2009 | US7582279 Surface modified lipoprotein-like oil in water emulsion having lipophilic core surrounded by monolayer of amphiphilic or polar lipids; polyoxyethylene glycol linked lipid and (choles)terol; radioactive or stable, synthetic polyhalogenated triglycerides as contrast agents; radiographic imaging |
08/27/2009 | US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
08/27/2009 | US20090214425 Tumor therapy with replication competent sindbis viral vectors |
08/27/2009 | US20090214424 Human glycoprotein hormone superagonists and uses thereof |
08/27/2009 | US20090214423 Selective targeting of tumor vasculature using radiolabelled antibody molecules |
08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
08/27/2009 | US20090214421 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
08/27/2009 | US20090214420 Method of Diagnosis and Treatment and Agents Useful for Same |
08/27/2009 | US20090214419 Self-assembled biodegradable polymersomes |
08/27/2009 | CA2715747A1 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging |
08/26/2009 | EP2092058A1 Cancerous disease modifying antibodies |
08/26/2009 | EP2091453A2 A system, method, computer-readable medium, and use for planning combined therapy |
08/26/2009 | CN101516408A Method for radiolabeling formulations for gamma scintigraphy assesment |
08/26/2009 | CN101516407A Improvement of arginase levels/activity |
08/26/2009 | CN100531798C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
08/25/2009 | US7579313 Transglutaminase inhibitors and methods of use thereof |
08/20/2009 | WO2009102384A2 Radiolabeled derivatives of potent chymase inhibitors |
08/20/2009 | WO2009102378A2 Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals |
08/20/2009 | US20090208414 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled ketones by photo-induced free radical carbonylation |
08/20/2009 | US20090208413 Registry Method and Control System for Dea Schedule II-V Medicines |
08/20/2009 | US20090208412 Contrast Agents |
08/20/2009 | US20090208411 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
08/20/2009 | US20090208410 Ed-b fibronectin as stratification marker for anti-tumor drugs |
08/20/2009 | US20090208409 Encapsulated nanoparticles for computed tomography imaging |
08/20/2009 | US20090208408 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
08/19/2009 | EP2089514A1 Cancerous disease modifying antibodies |
08/19/2009 | EP2089362A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
08/19/2009 | EP1933885B1 Automated radiolabelling method |
08/19/2009 | EP1740225A4 Contrast agents for myocardial perfusion imaging |
08/19/2009 | EP1463065B9 Processes for producing 15o-carbon monoxide and 15o-carbon dioxide and production apparatus |
08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
08/19/2009 | EP1119356B1 Radiolabeled neurokinin-1 receptor antagonists |
08/19/2009 | EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses |
08/19/2009 | CN101511389A Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition |
08/19/2009 | CN100528242C Radioactive macroaggregate and its preparation method |
08/19/2009 | CN100528241C Vitamin-targeted imaging agents |
08/18/2009 | US7575873 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
08/18/2009 | US7575738 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
08/18/2009 | CA2413736C Thorium or actinium radionuclides for endoradionuclide therapy |
08/13/2009 | WO2009100014A1 System for fluorinating organic compounds |
08/13/2009 | WO2009099636A1 Conjugation of small molecules to octaarginine transporters for overcoming multi-drug resistance |
08/13/2009 | WO2009018175A3 Cyclic azapeptides as integrin markers |
08/13/2009 | WO2009000777A3 Imaging diagnostics by combining contrast agents |
08/13/2009 | US20090203584 Peptide-based Compounds |
08/13/2009 | US20090203024 Secreted protein called 36p6d5 characteristic of tumors |
08/13/2009 | US20090202436 Bupivacaine Formulation in a Polyorthoester Carrier |
08/13/2009 | US20090202435 Diagnostic compounds for targeting a chemokine receptors |
08/13/2009 | US20090202434 Pharmaceutical Composition and Dressing for Treating Skin Lesion, as Well as the Use of Cerium Salt Associated With a Collagen Matrix |
08/13/2009 | US20090202433 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
08/13/2009 | US20090202432 Treatment and prophylaxis of amyloidosis |